Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Announces Upcoming 2016 Investor Conference Presentations

04/29/16

TARRYTOWN, N.Y., April 29, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations as follows: Bank of America Merrill Lynch Healthcare Conference at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) on Tuesday, May 10, 2016 Barclays 20...

Read more

Upcoming Events

Regeneron Pharmaceuticals Q1 2016 Earnings Conference Call

05/05/16 at 8:30 AM

View Event

Bank of America Merrill Lynch Healthcare Conference

05/10/16 at 8:00 AM PT

View Event




Close
Form content here please :)